4.7 Article

Mesenchymal Stromal Cells Protect Cancer Cells From ROS-induced Apoptosis and Enhance the Warburg Effect by Secreting STC1

期刊

MOLECULAR THERAPY
卷 20, 期 2, 页码 417-423

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/mt.2011.259

关键词

-

资金

  1. NIH [HL073755, HL073252, P01 HL075161]
  2. Louisiana Gene Therapy Research Consortium
  3. Ministry of Education, Culture, Sports, Science, and Technology in Japan [21590980, 20390229]
  4. Grants-in-Aid for Scientific Research [20390229, 23790895, 21590980] Funding Source: KAKEN

向作者/读者索取更多资源

Previous studies have demonstrated that mesenchymal stromal cells (MSCs) enhance cell survival through upregulation and secretion of stanniocalcin-1 (STC1). This study shows that MSC-derived STC1 promotes survival of lung cancer cells by uncoupling oxidative phosphorylation, reducing intracellular reactive oxygen species (ROS), and shifting metabolism towards a more glycolytic metabolic profile. MSC-derived STC1 upregulated uncoupling protein 2 (UCP2) in injured A549 cells in an STC1-dependent manner. Knockdown of UCP2 reduced the ability of MSCs and recombinant STC1 (rSTC1) to reduce cell death in the A549 population. rSTC1-treated A549 cells displayed decreased levels of ROS, mitochondrial membrane potential (MMP), and increased lactate production, all of which were dependent on the upregulation of UCP2. Our data suggest that MSCs can promote cell survival by regulating mitochondrial respiration via STC1.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据